Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. ISEC Healthcare's interest expense for the
three
months ended in Mar. 2026 was S$ -0.16 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was S$-0.64 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
ISEC Healthcare Interest Expense Historical Data
* Premium members only.
The historical data trend for ISEC Healthcare's Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was S$-0.64 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISEC Healthcare (SGX:40T) has a Interest Expense of S$-0.64 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on ISEC Healthcare and its competitors.
Is ISEC Healthcare's Interest Expense too high?
ISEC Healthcare's current Interest Expense is S$-0.64 Mil. Overall, ISEC Healthcare has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ISEC Healthcare's Interest Expense compare to HCA and THC?
ISEC Healthcare's Interest Expense of S$-0.64 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Healthcare Providers & Services company?
A good Interest Expense depends on the Healthcare Providers & Services industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on ISEC Healthcare and its competitors. ISEC Healthcare's current Interest Expense is S$-0.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ISEC Healthcare stock overvalued right now?
Based on GuruFocus' analysis, ISEC Healthcare (SGX:40T) is currently considered Modestly Undervalued. The stock's GF Value™ is S$0.45, compared to a current price of S$0.32 — trading 28.9% below its estimated fair value. The current Interest Expense is S$-0.64 Mil. ISEC Healthcare's overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For ISEC Healthcare (SGX:40T), the current Interest Expense is S$-0.64 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ISEC Healthcare (SGX:40T) Overvalued in 2026?
Based on GuruFocus' analysis, ISEC Healthcare stock appears to be undervalued.
The current stock price of S$0.32 is trading 28.9% below its estimated GF Value™ of S$0.45.
GuruFocus considers ISEC Healthcare to be Modestly Undervalued.
Key valuation signals for SGX:40T:
Interest Expense: S$-0.64 Mil
GF Value™: S$0.45 vs. price of S$0.32 (28.9% below fair value)
No single metric tells the full story. See the SGX:40T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ISEC Healthcare Ltd principal activity of the Company is that of an investment holding company. It is regional provider of comprehensive medical eye care services with ambulatory surgical centres. The company has two reportable segment which are Specialised health services: provision of medical care, consultancy, treatment and surgery in the field of ophthalmology; and General health services: provision of general medical and procedural treatment services. The majority of revenue comes from Specialised health services segment. The company has presence in Singapore, Malaysia, and Myanmar. The company generates majority of revenue from Malaysia.
66GF Score
Get the complete analysis for SGX:40T
Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:40T has been successfully added to your 
